Therma Bright (TSE:THRM) has released an update.
Therma Bright Inc. is enhancing its stake in InStatin as part of a strategic partnership with InVixa to develop innovative respiratory solutions, including a promising statin inhalant for asthma and COPD. This collaboration aims to leverage a growing market opportunity and bring effective treatments to individuals with acute lung diseases.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
